We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

ImClone Settles Patent Row With Yeda, Sanofi

Law360 (December 7, 2007, 12:00 AM EST) -- Biotech company ImClone Systems Inc. has inked a settlement agreement with Yeda Research and Development Company Ltd. and Sanofi-Aventis, putting to rest a patent dispute related to the cancer drug Erbitux,...
To view the full article, register now.